Pranay Srivastava

Pranay is an experienced pharmacologist with a background in drug discovery studies and boasts over ten years of experience designing and executing both in vivo and in vitro experiments to uncover the underlying pathophysiology of neurodegeneration and neuroinflammation. His extensive skill set includes a comprehensive suite of bioassays tailored to investigate the therapeutic potential of novel chemical entities (NCEs) across various neurological disorders. Pranay is a proficient scientist and a skilled project manager, adept at orchestrating multidisciplinary endeavors that foster cross-functional collaborations. 


He has earned a PhD in Pharmaceutical Sciences from BBD University, India and has 5 years of postdoctoral experience working at UCONN Health Center and Harvard Medical School. He further solidified his influence in the scientific community by conducting more than 100 reviews for journals, including PLoS One, Proceedings of the National Academy of Sciences, Biomedicines, and the International Journal of Molecular Sciences. Pranay's dedication to advancing the field has garnered him numerous accolades on the international stage, underscoring his commitment to groundbreaking research and innovation.